FdaApplication

NDA 202020

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHORIZON THERAPEUTICS USA INC
application_typeNDA
approval_date2012-07-26

Products (3)

ProductActive ingredientStrengthDosage form
RAYOSPREDNISONE5MGTABLET, DELAYED RELEASE;ORAL
RAYOSPREDNISONE2MGTABLET, DELAYED RELEASE;ORAL
RAYOSPREDNISONE1MGTABLET, DELAYED RELEASE;ORAL

3 products